Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health

Civil society organisations are calling on the German government to support the classification of Resorcinol as a substance of very high concern (SVHC) under the REACH regulation. They argue that Resorcinol is a known endocrine disruptor that inhibits thyroperoxidase (TPO), affecting thyroid hormone levels essential for brain development, particularly in unborn children. The authors highlight that Resorcinol is a high-volume compound used in cosmetics, pharmaceuticals, and rubber products, leading to significant exposure for workers and the public. They contend that the substance meets the 'equivalent level of concern' (ELoC) criteria due to the irreversible nature of its developmental effects, such as hypothyroidism and neurological impacts.

• Resorcinol is identified as an endocrine disruptor that inhibits thyroperoxidase (TPO), an enzyme critical for thyroid hormone synthesis, which is essential for prenatal brain development.
• Exposure to Resorcinol is linked to severe and potentially irreversible developmental effects in humans, including goiter, hypothyroidism, and neurological impacts in children.
• Resorcinol is a high-volume chemical registered at 1,000-10,000 tons per year and is used in various consumer and industrial applications, including adhesives, resins, flame retardants, pharmaceuticals, hygiene products, cosmetics, and rubber products.
• The authors argue that Resorcinol meets the 'equivalent level of concern' (ELoC) criteria under REACH article 57(f) because its effects on thyroid hormones severely impact long-term health and well-being and are not easily reversed.

APA

Jensen, G. K. (2021). Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health. ClientEarth. https://www.clientearth.org/media/kqfjrg5m/resorc_2.pdf

Chicago

Jensen, Genon K. Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health. ClientEarth, 2021. https://www.clientearth.org/media/kqfjrg5m/resorc_2.pdf.

Wikipedia

{{cite press release |last1=Jensen |first1=Genon K. |title=Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health |publisher=ClientEarth |date=6 September 2021 |url=https://www.clientearth.org/media/kqfjrg5m/resorc_2.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}

BibTeX

@misc{jensen2021resorcinol, author = {Jensen, Genon K.}, title = {{Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health}}, publisher = {ClientEarth}, year = {2021}, month = sep, url = {https://www.clientearth.org/media/kqfjrg5m/resorc_2.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }